We are delighted by today's decision to allow patients with advanced prostate cancer to receive abiraterone on the NHS.
This drug was discovered at the Institute of Cancer Research and is the result of more than two decades of dedicated work by our scientists and and collaborators.
In clinical trials of men with advanced prostate cancer who have already tried chemotherapy, it has been shown to extend life by an average of four months and improve quality of life.
More top news
It will be increasingly humid and thundery with highs of 30C or more today.
Holidaymakers in Tunisia are determined not to be beaten. But, as Neil Connery writes, it won't be easy to escape the shock of the massacre.
Drink lots of water, stay out of the sun during the middle of the day, and take particular care of vulnerable people.